Lemaitre Vascular (LMAT) FY2020 results: revenue $129 million, up 10.4% on the year
Lemaitre Vascular Inc. (LMAT) reported revenue of $129 million for fiscal 2020, the year ended 31 December 2020, up 10.4% on the year before. Net income was $21 million, up 18.3%, and diluted earnings per share $1.04. The figures are the company's own, from the 10-K it filed with the SEC on 12 March 2021.
Revenue
$129 million
+10.4% on the year
FY2013FY2020
Operating margin
22.3%
18.1% a year earlier
FY2013FY2020
Net income
$21 million
+18.3% on the year
FY2013FY2020
Diluted EPS
$1.04
+18.2% on the year
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
129
117
106
+10.4%
Cost of revenue
44.7
37.4
31.6
+19.7%
Gross profit
84.6
79.9
73.9
+6.0%
Gross margin
65.4%
68.1%
70.0%
Research and development
10.1
9.3
8.2
+8.9%
Operating income
28.8
21.2
28.2
+35.9%
Operating margin
22.3%
18.1%
26.7%
Interest expense
1.3
0.0
0.0
Pre-tax income
27.4
21.7
28.4
+26.2%
Income tax
6.1
3.7
5.5
+63.8%
Effective tax rate
22.4%
17.3%
19.3%
Net income
21.2
17.9
22.9
+18.3%
Net margin
16.4%
15.3%
21.7%
Diluted EPS
$1.04
$0.88
$1.13
+18.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
34.8
14.2
19.5
+145.4%
Capital expenditure
3.0
3.8
3.1
-20.7%
Free cash flow
31.8
10.4
16.5
+205.4%
Free cash flow margin
24.6%
8.9%
15.6%
Cash from investing
-52.9
-24.1
-7.1
Cash from financing
32.2
-4.6
-4.4
Depreciation and amortisation
8.4
5.4
4.3
+55.0%
Share-based compensation
3.0
2.6
2.3
+14.4%
Buybacks
0.6
0.7
0.7
-16.5%
Dividends paid
7.7
6.7
5.4
+14.2%
Dividend per share
$0.38
$0.34
$0.28
+11.8%
Diluted shares, weighted
20m
20m
20m
+0.8%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
173
148
130
+16.5%
Debt
38.0
0.0
0.0
Operating lease liabilities
14.8
14.0
n/a
+6.0%
Other liabilities
27.4
26.2
22.9
+4.5%
Total liabilities and equity
253
188
153
+34.2%
Fixed assets
15.0
14.9
14.1
+1.2%
Goodwill
65.9
40.0
29.9
+65.1%
Intangible assets
58.9
24.9
13.7
+136.6%
Investments
0.2
20.9
21.7
-99.0%
Cash and equivalents
26.8
11.8
26.3
+127.1%
Receivables
19.6
16.6
15.7
+18.0%
Other assets
66.4
59.4
31.7
+11.8%
Total assets
253
188
153
+34.2%
10-K for the year ended 31 December 2020, filed 12 March 2021: the filing.